Medical News

Canagliflozin Treatment Improves Health-Related Quality of Life in Type-2 Diabetes Patients

A substantially greater proportion of type-2 diabetes mellitus (T2DM) patients treated with canagliflozin rather than placebo or sitagliptin had...

15 Jan, 2018

 
Email this page
FDA Approves a Novel Shock Wave Device to Treat Diabetic Foot Ulcers

The U.S. Food and Drug Administration (FDA) has recently approved marketing of the first shock wave device proposed to treat diabetic foot ulcers.

12 Jan, 2018

 
Email this page
Type-2 Diabetes Remission Achievable with Primary Care-led Weight Management

A recent study demonstrated that appropriate weight loss and management initiated at the primary care level helped nearly 50% of the study...

09 Jan, 2018

 
Email this page
Low Birth Weight, A Potential Marker of Future Type-2 Diabetes Risk

Low birth weight increases the risk of type-2 diabetes mellitus (T2DM), as per a recent meta-analysis. On the contrary, high birth weight had no...

08 Jan, 2018

 
Email this page

eCMEs

Effective Doctor-Patient Communication - Module - 4: Role Plays & Conclusion

eCME/Videos

Speaker(s):
Dr. Anand Nadkarni
M.D., D.P.M., F.I.P.S.
Consultant Psychiatrist Institute for Psychological Health, Thane
Effective Doctor-Patient Communication - Module - 3: Approaches Towards Communication

eCME/Videos

Speaker(s):
Dr. Anand Nadkarni
M.D., D.P.M., F.I.P.S.
Consultant Psychiatrist Institute for Psychological Health, Thane
Effective Doctor-Patient Communication: Module - 2: Styles of Communication & Listening

eCME/Videos

Speaker(s):
Dr. Anand Nadkarni
M.D., D.P.M., F.I.P.S.
Consultant Psychiatrist Institute for Psychological Health, Thane

Key Trials

Benefits of Initial Combination Therapy of Vildagliptin/Metformin in Asian T2DM Patients

Combination therapy of vildagliptin/metformin demonstrated consistent HbA1c reduction across wide spectrum of drug naïve Asian T2DM patients.

Sacubitril/Valsartan Enhances Glycemic Control in Heart Failure Patients with Diabetes

As per the study sacubitril/valsartan causes greater reduction in HbA1c vs. enalapril and cuts new insulin initiation in diabetes patients with...

Azilsartan is Superior to Olmesartan in Hypertensives with Type 2 Diabetes/ Prediabetes

This study shows that azilsartan can be the preferred ARB in hypertensives with prediabetes or type 2 diabetes

Prevalence of Diabetes and Prediabetes in 15 States of India: Insights from the ICMR–INDIAB Population-Based Study

The Indian Council of Medical Research–INdia DIABetes (ICMR-INDIAB) study is an ongoing study initiated to estimate the national prevalence of...

Patient Education

Know More about Diabetes

Diabetes implies high blood sugar levels in blood. Find out more about the cause, risk factors and complications associated with this disease.

Yoga

The ancient science of yoga provides various health benefits to an individual. Know more about the ‘asanas’ that are beneficial for diabetes...

Stretching

Stretching improves our flexibility and physical performance. Understand the correct stretching techniques to reap maximum health benefits from them...

Walking

Walking is a simple exercise with numerous health benefits for all.  A simple, step-wise walking program is important for effective diabetes control...

Our Publications

Mind Matters (Issue 3) - Role of Escitalopram in the Treatment of Comorbid Depression and Diabetes

The presence of depression in patients with diabetes mellitus is of vast importance, as it is usually associated with poor disease control, adverse...

Diabetes Management Series: Cholesterol

Most relevant information on management of dyslipidemia, a common comorbidity observed in diabetes patients, has been summarised in this document.

Drug Therapy for Management of Hyperglycaemia

Brief information on the treatment strategy and selection of oral antihyperglycemic agents in type 2 diabetes is summarised in this document.

Diabetes Management Series: Hypertension

Hypertension elevates the risk of micro-and macro-vascular complications in diabetes. Here is a summary on the BP treatment goals in diabetes...

Slide Library

Clinical Practice Recommendations: ADA 2014

This slide set summarizes the key 2014 clinical practice recommendations of the American Diabetes Association (ADA) on the screening, diagnosis and...

 
Email this page
Diabetic Dyslipidemia

Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes mellitus. This slide set provides information on the...

 
Email this page
Treating Hypertension in Diabetics : Optimal Selection of Antihypertensive Therapy

Hypertension affects 20%-60% of diabetics. It substantially increases the risk of macrovascular and microvascular complications in diabetes. This...

 
Email this page
The ‘Four Facets’ of Glucose Control: Focus on Voglibose and Metformin Combination

This slide set addresses the need to progress from the glucose triad to the glucose pyramid for achieving steady glucose control. The effectiveness...

 
Email this page

Poll

Which is your preferred DPP4 inhibitor for your type 2 diabetes patients with ESRD?
Sitagliptin
0% (0 votes)
Vildagliptin
50% (2 votes)
Linagliptin
25% (1 vote)
No specific choice
25% (1 vote)
Don’t prefer a DPP4 inhibitor
0% (0 votes)
Total votes: 4